High Prevalence of B-RAF Mutation in Papillary Carcinoma of the Thyroid in North-East Italy

Abstract

B-RAF V600E mutation is frequently observed in several tumors, including papillary thyroid carcinomas (PTCs), where it is considered of potential diagnostic and prognostic value. The reported prevalence of B-RAF mutation in PTCs in different Italian populations varies from 14% to 69%. The authors investigate the prevalence and utility of the B-RAF V600E mutation in a series of 91 fine needle aspiration biopsies (FNABs) of the thyroid and in 60 histologically proven PTCs in a well-defined north Italian population. In their series, the B-RAF mutation was detected in 43 (72%) PTCs and was more frequent in classic (34 out of 44, 77%) versus variant follicular PTCs (PTCVF; 9 out of 16, 56%). In all, 41 (46%) FNABs showed B-RAF mutation and corresponded to histologically proven PTCs (33 classic type and 8 PTCVF), which had been cytologically classified as malignant (28 cases), atypical/suspicious (10), inadequate (1), and benign (2). B-RAF mutations were never seen in non-PTC/ PTCVF FNAB cases, implying a 100% positive predictive value.These data demonstrate a high prevalence of B-RAF mutations in the present study population, underscoring the possibility of strong regional differences in B-RAF mutation prevalence in PTCs and further confirming its high diagnostic value on FNAB.

Keywords

B-RAF papillary carcinoma of the thyroid fine needle aspiration cytology molecular pathology mutational analysis

References

Santoro M. , Carlomagno F. , Hay ID , et al. Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype. J Clin Invest. 1992;89:1517-1522.

Bongarzone I. , Vigneri P. , Mariani L. , Collini P. , Pilotti S. , Pierotti MA RET/NTRK1 rearrangements in thyroid gland tumors of the papillary carcinoma family: correlation with clinicopathological features. Clin Cancer Res. 1998;4:223-228.

Cohen Y. , Rosenbaum E. , Clark DP , et al. Mutational analysis of BRAF in fine needle aspiration biopsies of the thyroid: a potential application for the preoperative assessment of thyroid nodules. Clin Cancer Res. 2004;10:2761-2765.

Namba H. , Nakashima M. , Hayashi T. , et al. Clinical implication of hot spot BRAF mutation, V599E, in papillary thyroid cancers. J Clin Endocrinol Metab. 2003;88:4393-4397.

Nikiforova MN , Kimura ET , Gandhi M. , et al. BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas. J Clin Endocrinol Metab. 2003;88: 5399-5404.

Soares P. , Trovisco V. , Rocha AS , et al. BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC. Oncogene. 2003;22:4578-4580.

Hayashida N. , Namba H. , Kumagai A. , et al. A rapid and simple detection method for the BRAF(T1796A) mutation in fine-needle aspirated thyroid carcinoma cells . Thyroid. 2004;14:910-915.

Chiosea S. , Nikiforova M. , Zuo H. , et al. A novel complex BRAF mutation detected in a solid variant of papillary thyroid carcinoma. Endocr Pathol. 2009;20:122-126.

De FV , Giannini R. , Tamburrino A. , et al. Functional characterization of the novel T599I-VKSRdel BRAF mutation in a follicular variant papillary thyroid carcinoma. J Clin Endocrinol Metab. 2008;93:4398-4402.

10.

Troncone G. , Cozzolino I. , Fedele M. , Malapelle U. , Palombini L. Preparation of thyroid FNA material for routine cytology and BRAF testing: a validation study [published online ahead of print August 19, 2009]. Diagn Cytopathol. 2009 Aug 19;38(3):172-176.

11.

Xing M. BRAF mutation in papillary thyroid microcarcinoma: the promise of better risk management. Ann Surg Oncol. 2009;16:801-803.

12.

Moon HJ , Kwak JY , Kim EK , et al. The role of BRAF(V600E) mutation and ultrasonography for the surgical management of a thyroid nodule suspicious for papillary thyroid carcinoma on cytology [published online ahead of print July 31, 2009]. Ann Surg Oncol. 2009 Nov;16(11):3125-31.

13.

Nikiforova MN , Nikiforov YE Molecular genetics of thyroid cancer: implications for diagnosis, treatment and prognosis. Expert Rev Mol Diagn . 2008;8:83-95.

14.

Lee JH , Lee ES , Kim YS Clinicopathologic significance of BRAF V600E mutation in papillary carcinomas of the thyroid: a meta-analysis. Cancer. 2007 ;110:38-46.

15.

Chung KW , Yang SK , Lee GK , et al. Detection of BRAFV600E mutation on fine needle aspiration specimens of thyroid nodule refines cyto-pathology diagnosis, especially in BRAF600E mutation-prevalent area. Clin Endocrinol ( Oxf). 2006;65:660-666.

16.

Nikiforov YE Thyroid carcinoma: molecular pathways and therapeutic targets. Mod Pathol. 2008;21(suppl 2): S37-S43.

17.

Zatelli MC , Trasforini G. , Leoni S. , et al. BRAF V600E mutation analysis increases diagnostic accuracy for papillary thyroid carcinoma in fine-needle aspiration biopsies. Eur J Endocrinol. 2009;161:467-473.

18.

Rowe LR , Bentz BG , Bentz JS Detection of BRAF V600E activating mutation in papillary thyroid carcinoma using PCR with allele-specific fluorescent probe melting curve analysis. J Clin Pathol. 2007;60:1211-1215.

19.

Frattini M. , Ferrario C. , Bressan P. , et al. Alternative mutations of BRAF, RET and NTRK1 are associated with similar but distinct gene expression patterns in papillary thyroid cancer. Oncogene. 2004 ;23:7436-7440.

20.

Salvatore G. , Giannini R. , Faviana P. , et al. Analysis of BRAF point mutation and RET/PTC rearrangement refines the fine-needle aspiration diagnosis of papillary thyroid carcinoma. J Clin Endocrinol Metab. 2004;89:5175-5180.

21.

Carta C. , Moretti S. , Passeri L. , et al. Genotyping of an Italian papillary thyroid carcinoma cohort revealed high prevalence of BRAF mutations, absence of RAS mutations and allowed the detection of a new mutation of BRAF oncoprotein (BRAF(V599lns)). Clin Endocrinol (Oxf). 2006;64:105-109.

22.

Fugazzola L. , Puxeddu E. , Avenia N. , et al. Correlation between B-RAFV600E mutation and clinico-pathologic parameters in papillary thyroid carcinoma: data from a multicentric Italian study and review of the literature. Endocr Relat Cancer. 2006;13:455-464.

23.

Sapio MR , Posca D. , Raggioli A. , et al. Detection of RET/ PTC, TRK and BRAF mutations in preoperative diagnosis of thyroid nodules with indeterminate cytological findings. Clin Endocrinol (Oxf). 2007;66:678-683.

24.

Frasca F. , Nucera C. , Pellegriti G. , et al. BRAF(V600E) mutation and the biology of papillary thyroid cancer . Endocr Relat Cancer. 2008;15:191-205.